학술논문
Pembrolizumab for advanced non-small cell lung cancer (NSCLC): Impact of autoimmune comorbidity and outcomes following treatment completion
Document Type
Article
Author
Source
In: Journal of Oncology Pharmacy Practice . (Journal of Oncology Pharmacy Practice, June 2023, 29(4):785-793)
Subject
Language
English
ISSN
1477092X
10781552
10781552